- Alkermes (company)
Alkermes, Inc. NASDAQ|ALKS is a
pharmaceutical company headquartered in Cambridge,Massachusetts with manufacturing facilities in Wilmington,Ohio and Chelsea, Massachusetts.Alexander Rich , MD is the founder and director since 1987. The company focuses ondrug delivery technologies, including "long-acting" or "extended release" formulations of injectable and inhaled drugs. The technology has currently been applied to "small molecule" type drugs, andpeptide hormone s. Typically, Alkermes applies its technology to anactive ingredient owned by a partner company, although it is pursuing the development of at least oneproprietary drug as well.Their main product is "Risperdal Consta", which is a long acting version of
Johnson & Johnson 's Risperidone. The drug is anatypical antipsychotic used in the treatment ofschizophrenia . OnApril 13 ,2006 Alkermes andCephalon, Inc. receivedFood and Drug Administration approval of "Vivitrol " (formerly "Vivitrex") for the treatment ofalcohol dependence .cite news
url=http://today.reuters.com/news/articlenews.aspx?type=healthNews&storyid=2006-04-13T223238Z_01_N13253127_RTRUKOC_0_US-ALCOHOL.xml
publisher=Reuters
title=Monthly drug for alcoholism gets FDA approval
date=April 13, 2006]
Eli Lilly and Company is working with Alkermes to develop a new version of inhaledinsulin for type 1 diabetics, and an extended release formulation ofParathyroid hormone to treatosteoporosis . Both companies are also collaborating withAmylin to develop and market a long-acting version of Amylin's "Byetta " called "Exenatide LAR" for the treatment of type 2 diabetes.From
1999 to2004 , Alkermes andGenentech marketed "Nutropin Depot" (long actingsomatropin forgrowth hormone deficiency ) , but the product was withdrawn due to high manufacturing costs. Currently, Alkermes and Lilly are developing an inhaled version of thehormone .Independently, Alkermes is pursuing an inhaled version of
epinephrine foranaphylaxis (allergic shock).External links
* [http://www.alkermes.com/ Alkermes, Inc.]
References
Wikimedia Foundation. 2010.